Web17 Mar 2024 · TFE3 rearranged carcinoma with papillary and alveolar growth pattern, composed of clear to eosinophilic discohesive pseudostratified cells with voluminous cytoplasm, high grade nuclei and psammoma bodies; there is strong diffuse nuclear positivity for TFE3 by immunohistochemistry TFEB rearranged carcinoma with biphasic WebImmunohistochemical staining for TFE3 was performed in 303 cases, and FISH analysis was performed for molecular testing. The TCGA data set of renal cell carcinoma was …
Anti-TFE3 Antibodies Invitrogen - Thermo Fisher Scientific
WebCaris molecular profiling has the ability to detect rare fusion events far better than DNA-based short-read methods, and provides broad coverage of all exons, capturing all possible fusion partners. Immunohistochemistry (IHC): Caris evaluates protein biomarkers through an extensive immunohistochemical panel analyzed in a tumor-type specific ... WebMetastatic ASPS is resistant to conventional systemic therapies associated with microphthalmia transcription factor (MiT). 1,8 The MiT gene family includes TFE3, TFEB, TFEC, and MiTF. 20 ASPSCR1-TFE3 causes MET autophosphorylation and activation of downstream signaling such as PI3K/AKT and MAPK. 21 These pathways drive … roadside reflectors meamings
TFE3 Antibody Cell Signaling Technology
Web11 Aug 2024 · Molecular testing All cases in the cohort were molecularly confirmed to harbor YAP1-TFE3 gene fusions: 17 cases were confirmed by RNA-sequencing (RNA-seq); … Web27 Jan 2024 · TFEB and TFE3 are master transcriptional regulators of autophagy and lysosomal activity and their cytoplasm/nuclear shuttling is controlled by mTORC1-dependent multisite phosphorylation. However, it is not known whether and how the transcriptional activity of TFEB or TFE3 is regulated. Webgenes in panel. prev next aars 4 abat 6 acox1 4 actl6b 3 adar 4 adarb1 2 adgrg1 4 adprhl2 6 adsl 6 aff3 5 aimp1 4 akt3 4 aldh5a1 4 aldh7a1 9 alg1 4 alg11 3 alg13 sncb ans